findmyKOL
Clinical trialNCT00023400CompletedPhase 4Interventional

TBTC Study 23B:Intensive PK of the Nelfinavir Rifabutin Interaction in Patients With HIV-TB

SponsorCenters for Disease Control and PreventionEnrollment20HIV InfectionsTuberculosis
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

23 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada
  • University of British Columbia

    Vancouver, British Columbia, Canada

  • University of Manitoba

    Winnipeg, Manitoba, Canada

  • Montreal Chest Institute Mcgill University

    Montreal, Quebec, Canada

United States
  • Central Arkansas Veterans Health System

    Little Rock, Arkansas, United States

  • la County/usc Medical Center

    Los Angeles, California, United States

  • University of California, San Francisco

    San Francisco, California, United States

  • Denver Department of Public Health and Hospitals

    Denver, Colorado, United States

  • Washington, D.C. Vamc

    Washington D.C., District of Columbia, United States

  • Chicago Va Medical Center (lakeside)

    Chicago, Illinois, United States

  • Hines Va Medical Center

    Hines, Illinois, United States

  • Johns Hopkins University School of Medicine

    Baltimore, Maryland, United States

  • Boston Medical Center

    Boston, Massachusetts, United States

  • New Jersey Medical School

    Newark, New Jersey, United States

  • Columbia University/presbyterian Medical Center

    New York, New York, United States

  • Harlem Hospital Center

    New York, New York, United States

  • New York University School of Medicine

    New York, New York, United States

  • Carolinas Medical Center

    Charlotte, North Carolina, United States

  • Duke University Medical Center

    Durham, North Carolina, United States

  • Nashville Va Medical Center

    Nashville, Tennessee, United States

  • University of North Texas Health Science Center

    Fort Worth, Texas, United States

  • Thomas Street Clinic

    Houston, Texas, United States

  • Audi L. Murphy Va Hospital

    San Antonio, Texas, United States

  • Seattle King County Health Department

    Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
29 Feb 2000
Primary completion
Completion
28 Feb 2002
Last update posted
5 Sept 2005
Registered enrollment
20
Registry id
NCT00023400

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.